The Annual Meeting Point for the European ADC Community
With Topo1 and MMAE payloads continuing to dominate the ADC landscape, competition around validated tumour targets intensifying, and patient resistance mechanisms emerging as one of the industry's greatest challenges, differentiation has become the defining priority for the next generation of ADC development.
Fuelled by the race to develop the next blockbuster beyond Enhertu, biopharma is investing heavily in novel approaches to future-proof ADC pipelines with quicker candidate selection, faster translation, and shorter manufacturing timelines. This is driving rapid growth across bispecific ADCs, dual-payload ADCs, oligonucleotide antibody conjugates, and beyond.
However, this isn’t differentiation for differentiation’s sake. Now the goal is to deliver the greatest benefit for more patients.
The definitive 17th World ADC London remains Europe's premier meeting for global scientific innovation and connection building across ADC discovery, clinical development, regulatory CMC, and manufacturing. Providing you a roadmap to future proof your ADC programmes in development.
Whether you're looking to de-risk development, differentiate your pipeline, or identify the next breakthrough ADC platform, World ADC London is the industry's must-attend forum to uncover cutting-edge science, forge strategic partnerships, and solidify the next wave of ADCs as standard of care therapies.
Your Guide to the Scientific & Strategic Innovations Defining 2027
Whether you're building foundational knowledge or advancing technical expertise, customise your World ADC London experience with content covering every stage of ADC development. Here's a preview of what's in store:
Seminar Day – Monday, 8th March
Ahead of the main conference days, the Seminar Day is your opportunity to get ahead of the curve. Dive deep into the biggest ADC challenges and bottlenecks with guidance from leading industry experts, uncover emerging solutions, and arrive fully prepared to maximise every moment of the conference.
Introduction to ADCs: Gaining familiarity with the fundamentals of ADC design and development
5th Novel Conjugates Day: Discover novel payloads and targeting moieties to stay ahead of the ADC design curve
4th Toxicity Day: Characterise and mitigate ADC toxicity to deliver safer and more effective ADCs
5th ADCs in Combination Day: Optimise ADC combination strategy to elevate clinical impact and overcome resistance
3rd Regulatory CMC Day: Understand regulatory expectations to accelerate your ADC submission strategy
ADC Licensing, Partnering & Investment Session – Open to all Registered Attendees
Scientific Programme Day One & Two – Tuesday, 9th – Wednesday, 10th March
From blockbuster clinical data to next-generation innovation across China, senior ADC leaders are set to deliver end-to-end development insights in keynote plenaries and across five content tracks.
- Discovery
- Preclinical & Translational
- Clinical Lessons
- Process & Analytical Development
- Manufacturing & Supply Chain
In addition to the latest scientific breakthroughs, you'll have access to structured and informal networking opportunities, as well as dedicated partnering discussions, enabling you to connect with peers, meet new collaborators, and explore potential scientific and business partnerships to accelerate your 2027 ADC development goals.
After the scientific presentations on Day One, you can enjoy a drink at the annual Evening Drinks Reception!
Workshop Day – Thursday, 11th March
Continue the conversation with peers through interactive discussions, debates, and collaborative sessions at the annual Post-Conference Workshop Day. Designed to tackle the biggest challenges in ADC development from key experts, here’s a snapshot of sessions you can take part in:
- Optimising Payload, Linker & Conjugation Strategies for Next-Generation Bioconjugates
- Accelerating ADC Model Simulation with the Power of Artificial Intelligence
- Strategic Approaches to Building A Patent Portfolio for an ADC
- Selecting & Validating the Most Suitable In Vitro & In Vivo Models to Overcome Resistance & Improve ADC Efficacy & Safety
- Overcoming the Challenges in Process Development & Manufacturing of Complex ADCs
More Than a Meeting: Make the Most of the World ADC Experience
As 700+ ADC decision-makers from Europe, the United States, Asia and beyond come together at the first major ADC event of 2027, you'll gain more than scientific insights. Build valuable connections through four days of structured networking, facilitated introductions and informal social events, including:
Brand-New Partnering Meeting App
Exhibition Booth Networking
Structured & Private Meeting Spaces
Scientific Poster Session
ADC Licensing, Partnering & Investment Session
Evening Drinks Reception
Explore the Preliminary Agenda
- 700+ ADC Industry Leaders Across Biopharma, Academia & Solution Providers
- 110+ Global ADC Experts & Industry Visionaries
- 5 Tracks of End-to-End ADC Innovation
- Brand-New Partnering Platform & Enhanced Networking Experiences
- Europe's Largest Gathering of the ADC Community
Brand New Presenting Companies for 2027:
Explore the Preliminary Agenda
Hear the latest industry insights and discover cutting-edge, end-to-end ADC content from early discovery to late-stage manufacturing.
Partner With Us
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals.
Join Biopharma Experts
Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.